{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:39Z","timestamp":1792783119216,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Foundation of Korea","award":["RS-2023-00250982"],"award-info":[{"award-number":["RS-2023-00250982"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Research Foundation of Korea","award":["2021R1I1A1A01056265"],"award-info":[{"award-number":["2021R1I1A1A01056265"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12763-1","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:22Z","timestamp":1789545862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interleukin-1\u03b2 potentiates transforming growth factor-\u03b2-induced fibronectin expression, migration, and invasiveness of mesenchymal-like SK-Hep1 cells via p38 mitogen-activated protein kinase\u2013SMAD2\/3 crosstalk"],"prefix":"10.1007","volume":"53","author":[{"given":"Saher","family":"Fatima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupendra","family":"Regmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonjae","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Koo","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Woo","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"3","key":"12763_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12763_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM et al (2021) Hepatocellular carcinoma. Nat Rev Dis Primers 7(1):6","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"12763_CR3","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG et al (2023) AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78(6):1922\u20131965","journal-title":"Hepatology"},{"issue":"15","key":"12763_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular Carcinoma. N Engl J Med 380(15):1450\u20131462","journal-title":"N Engl J Med"},{"issue":"10","key":"12763_CR5","doi-asserted-by":"publisher","first-page":"e110744","DOI":"10.1371\/journal.pone.0110744","volume":"9","author":"JR Eun","year":"2014","unstructured":"Eun JR et al (2014) Hepatoma SK Hep-1 cells exhibit characteristics of oncogenic mesenchymal stem cells with highly metastatic capacity. PLoS ONE 9(10):e110744","journal-title":"PLoS ONE"},{"issue":"18","key":"12763_CR6","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","volume":"20","author":"Z Peng","year":"2014","unstructured":"Peng Z et al (2014) Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol 20(18):5403\u20135410","journal-title":"World J Gastroenterol"},{"issue":"1","key":"12763_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12967-024-05411-4","volume":"22","author":"AO Giarratana","year":"2024","unstructured":"Giarratana AO et al (2024) TGF-\u03b2 signaling: critical nexus of fibrogenesis and cancer. J Transl Med 22(1):594","journal-title":"J Transl Med"},{"key":"12763_CR8","doi-asserted-by":"crossref","unstructured":"Caja L et al (2018) TGF-\u03b2 and the Tissue Microenvironment: Relevance in Fibrosis and Cancer. Int J Mol Sci 19(5):1294","DOI":"10.3390\/ijms19051294"},{"key":"12763_CR9","doi-asserted-by":"publisher","first-page":"734749","DOI":"10.3389\/fcell.2021.734749","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W et al (2021) TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis. Front Cell Dev Biol 9:734749","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"12763_CR10","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.7150\/ijbs.72367","volume":"18","author":"Z Peng","year":"2022","unstructured":"Peng Z et al (2022) The interactions between integrin \u03b1(5)\u03b2(1) of liver cancer cells and fibronectin of fibroblasts promote tumor growth and angiogenesis. Int J Biol Sci 18(13):5019\u20135037","journal-title":"Int J Biol Sci"},{"issue":"5","key":"12763_CR11","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1007\/s11033-011-1413-y","volume":"39","author":"ZL Xiang","year":"2012","unstructured":"Xiang ZL et al (2012) Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma. Mol Biol Rep 39(5):6001\u20136006","journal-title":"Mol Biol Rep"},{"issue":"1","key":"12763_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00441-011-1201-y","volume":"347","author":"Y Mu","year":"2012","unstructured":"Mu Y, Gudey SK, Landstr\u00f6m M (2012) Non-Smad signaling pathways. Cell Tissue Res 347(1):11\u201320","journal-title":"Cell Tissue Res"},{"issue":"3","key":"12763_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbrc.2012.09.103","volume":"427","author":"E Bae","year":"2012","unstructured":"Bae E et al (2012) Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-\u03b21\/Smad3-induced epithelial\u2013mesenchymal transition in renal epithelial cells. Biochem Biophys Res Commun 427(3):593\u2013599","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"12763_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 51(1):27\u201341","journal-title":"Immunity"},{"issue":"7","key":"12763_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41419-024-06888-z","volume":"15","author":"D Li","year":"2024","unstructured":"Li D et al (2024) Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma. Cell Death Dis 15(7):498","journal-title":"Cell Death Dis"},{"issue":"8","key":"12763_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/jhbp.12009","volume":"31","author":"Y Namba","year":"2024","unstructured":"Namba Y et al (2024) Effect of genetic polymorphisms of interleukin-1 beta on the microscopic portal vein invasion and prognosis of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 31(8):528\u2013536","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"12763_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA (2018) Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 281(1):8\u201327","journal-title":"Immunol Rev"},{"issue":"7","key":"12763_CR18","doi-asserted-by":"publisher","first-page":"e202012071","DOI":"10.1083\/jcb.202012071","volume":"220","author":"R Deliz-Aguirre","year":"2021","unstructured":"Deliz-Aguirre R et al (2021) MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling. J Cell Biol 220(7):e202012071","journal-title":"J Cell Biol"},{"issue":"7","key":"12763_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2017.17","volume":"24","author":"P Cohen","year":"2017","unstructured":"Cohen P, Strickson S (2017) The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways. Cell Death Differ 24(7):1153\u20131159","journal-title":"Cell Death Differ"},{"issue":"8","key":"12763_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/cancers11081053","volume":"11","author":"C Czauderna","year":"2019","unstructured":"Czauderna C et al (2019) Context-Dependent Role of NF-\u03baB Signaling in Primary Liver Cancer-from Tumor Development to Therapeutic Implications. Cancers (Basel) 11(8):1053","journal-title":"Cancers (Basel)"},{"issue":"23","key":"12763_CR21","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41388-022-02329-3","volume":"41","author":"S Kudaravalli","year":"2022","unstructured":"Kudaravalli S, Hollander Pden, Mani SA (2022) Role of p38 MAP kinase in cancer stem cells and metastasis. Oncogene 41(23):3177\u20133185","journal-title":"Oncogene"},{"issue":"3","key":"12763_CR22","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1002\/mog2.53","volume":"2","author":"Q Zheng","year":"2023","unstructured":"Zheng Q et al (2023) p38 mitogen-activated protein kinase: Functions and targeted therapy in diseases. MedComm\u2013Oncology 2(3):e53","journal-title":"MedComm\u2013Oncology"},{"key":"12763_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-4598-13-18","volume":"13","author":"Q Huang","year":"2014","unstructured":"Huang Q et al (2014) IL-1\u03b2-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1\/c-fos, MMP2 and MMP9. Mol Cancer 13:18","journal-title":"Mol Cancer"},{"issue":"1","key":"12763_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40001-022-00781-1","volume":"27","author":"A Xu","year":"2022","unstructured":"Xu A et al (2022) IL-1\u03b2 promotes A7r5 and HASMC migration and invasion via the p38-MAPK\/Angpt-2 pathway. Eur J Med Res 27(1):153","journal-title":"Eur J Med Res"},{"issue":"26","key":"12763_CR25","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.7150\/jca.35626","volume":"10","author":"WH Hsu","year":"2019","unstructured":"Hsu WH et al (2019) Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK\/MMP2 pathways. J Cancer 10(26):6716\u20136725","journal-title":"J Cancer"},{"issue":"3","key":"12763_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3892\/ol.2014.2255","volume":"8","author":"Y Tan","year":"2014","unstructured":"Tan Y et al (2014) Crosstalk between the p38 and TGF\u2013\u03b2 signaling pathways through T\u03b2RI, T\u03b2RII and Smad3 expression in plancental choriocarcinoma JEG\u20133 cells. Oncol Lett 8(3):1307\u20131311","journal-title":"Oncol Lett"},{"issue":"5","key":"12763_CR27","doi-asserted-by":"publisher","first-page":"e0266409","DOI":"10.1371\/journal.pone.0266409","volume":"17","author":"M-K Oh","year":"2022","unstructured":"Oh M-K, Joo H, Kim I-S (2022) Prohaptoglobin inhibits the transforming growth factor-\u03b2-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1\/5 activation and suppressing the Smad2\/3 signaling pathway in SK-Hep1 liver cancer cells. PLoS ONE 17(5):e0266409","journal-title":"PLoS ONE"},{"issue":"5","key":"12763_CR28","doi-asserted-by":"publisher","first-page":"e0232356","DOI":"10.1371\/journal.pone.0232356","volume":"15","author":"Y Yoshimatsu","year":"2020","unstructured":"Yoshimatsu Y et al (2020) TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals. PLoS ONE 15(5):e0232356","journal-title":"PLoS ONE"},{"issue":"5","key":"12763_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/biom12050635","volume":"12","author":"P Mallikarjuna","year":"2022","unstructured":"Mallikarjuna P, Zhou Y, Landstr\u00f6m M (2022) The synergistic cooperation between TGF-\u03b2 and hypoxia in cancer and fibrosis. Biomolecules 12(5):635","journal-title":"Biomolecules"},{"issue":"8","key":"12763_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","volume":"20","author":"JZ Kechagia","year":"2019","unstructured":"Kechagia JZ, Ivaska J, Roca-Cusachs P (2019) Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol 20(8):457\u2013473","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"12763_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40164-021-00212-7","volume":"10","author":"S Yang","year":"2021","unstructured":"Yang S et al (2021) SEPHS1 promotes SMAD2\/3\/4 expression and hepatocellular carcinoma cells invasion. Exp Hematol Oncol 10(1):17","journal-title":"Exp Hematol Oncol"},{"issue":"11","key":"12763_CR32","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1083\/jcb.201702033","volume":"216","author":"Y Attieh","year":"2017","unstructured":"Attieh Y et al (2017) Cancer-associated fibroblasts lead tumor invasion through integrin-\u03b23\u2013dependent fibronectin assembly. J Cell Biol 216(11):3509\u20133520","journal-title":"J Cell Biol"},{"issue":"6","key":"12763_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.molcel.2014.08.006","volume":"55","author":"R Ferrao","year":"2014","unstructured":"Ferrao R et al (2014) IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. Mol Cell 55(6):891\u2013903","journal-title":"Mol Cell"},{"issue":"5","key":"12763_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2013.01.056","volume":"144","author":"L Yang","year":"2013","unstructured":"Yang L et al (2013) Transforming growth factor\u2013\u03b2 signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology 144(5):1042\u20131054e4","journal-title":"Gastroenterology"},{"issue":"4","key":"12763_CR35","first-page":"401","volume":"43","author":"RN Mehr","year":"2018","unstructured":"Mehr RN et al (2018) Reactive oxygen species and p38MAPK Have a role in the Smad2 linker region phosphorylation induced by TGF-\u03b2. Iran J Med Sci 43(4):401","journal-title":"Iran J Med Sci"},{"issue":"7","key":"12763_CR36","first-page":"6588","volume":"16","author":"YM Sun","year":"2024","unstructured":"Sun YM et al (2024) TGF-\u03b2 downstream of Smad3 and MAPK signaling antagonistically regulate the viability and partial epithelial-mesenchymal transition of liver progenitor cells. Aging 16(7):6588\u20136612","journal-title":"Aging"},{"issue":"1","key":"12763_CR37","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1038\/ncomms3562","volume":"4","author":"SM Jung","year":"2013","unstructured":"Jung SM et al (2013) Smad6 inhibits non-canonical TGF-\u03b21 signalling by recruiting the deubiquitinase A20 to TRAF6. Nat Commun 4(1):2562","journal-title":"Nat Commun"},{"issue":"5","key":"12763_CR38","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1158\/1078-0432.CCR-15-1718","volume":"22","author":"A Patnaik","year":"2016","unstructured":"Patnaik A et al (2016) A first-in-human phase I study of the oral p38 MAPK inhibitor, ralimetinib (LY2228820 dimesylate), in patients with advanced cancer. Clin Cancer Res 22(5):1095\u20131102","journal-title":"Clin Cancer Res"},{"issue":"24","key":"12763_CR39","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-19-3176","volume":"80","author":"CC Wong","year":"2020","unstructured":"Wong CC et al (2020) Inhibition of IL1\u03b2 by canakinumab may be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial. Cancer Res 80(24):5597\u20135605","journal-title":"Cancer Res"},{"issue":"2","key":"12763_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1200\/JCO.23.00980","volume":"42","author":"DS Tan","year":"2024","unstructured":"Tan DS et al (2024) Canakinumab versus placebo in combination with first-line pembrolizumab plus chemotherapy for advanced non\u2013small-cell lung cancer: results from the CANOPY-1 trial. J Clin Oncol 42(2):192\u2013204","journal-title":"J Clin Oncol"},{"key":"12763_CR41","doi-asserted-by":"publisher","first-page":"217191","DOI":"10.1016\/j.canlet.2024.217191","volume":"604","author":"H Han","year":"2024","unstructured":"Han H et al (2024) RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma. Cancer Lett 604:217191","journal-title":"Cancer Lett"},{"issue":"41","key":"12763_CR42","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41388-025-03550-6","volume":"44","author":"H Han","year":"2025","unstructured":"Han H et al (2025) RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma. Oncogene 44(41):3955\u20133973","journal-title":"Oncogene"},{"issue":"40","key":"12763_CR43","doi-asserted-by":"publisher","first-page":"e09477","DOI":"10.1002\/advs.202509477","volume":"12","author":"H Han","year":"2025","unstructured":"Han H et al (2025) ASH2L-K312\u2010Lac stimulates angiogenesis in tumors to expedite the malignant progression of hepatocellular carcinoma. Adv Sci 12(40):e09477","journal-title":"Adv Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12763-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12763-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:04:26Z","timestamp":1789545866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12763-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12763"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12763-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1580"}}